These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3014173)

  • 21. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
    Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW
    JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An immunoglobulin G capture assay (GACRIA) for anti-HTLV III/LAV and its use as a confirmatory test.
    Parry JV
    J Med Virol; 1986 Aug; 19(4):387-97. PubMed ID: 3018141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which anti-HTLV III/LAV assays for screening and confirmatory testing?
    Mortimer PP; Parry JV; Mortimer JY
    Lancet; 1985 Oct; 2(8460):873-7. PubMed ID: 2864587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
    Abb J
    AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a combined HIV-1/2 and HTLV-I/II assay for screening blood donors.
    Flanagan P; McAlpine L; Ramskill SJ; Smith AG; Eglin R; Parry JV; Mortimer PP
    Vox Sang; 1995; 68(4):220-4. PubMed ID: 7660640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of an enzyme immunoassay for detection of antibody to human immunodeficiency virus in low risk populations.
    Peetoom F
    Transfusion; 1986; 26(6):536-8. PubMed ID: 3535179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis?
    Osterholm MT; Bowman RJ; Chopek MW; McCullough JJ; Korlath JA; Polesky HF
    N Engl J Med; 1985 May; 312(18):1185-9. PubMed ID: 2984568
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of serological cross-reactivity between antibodies to Plasmodium and HTLV-III/LAV.
    Greenberg AE; Schable CA; Sulzer AJ; Collins WE; Phuc Nguyen-Dinh
    Lancet; 1986 Aug; 2(8501):247-9. PubMed ID: 2874279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence of antibodies against LAV/HTLV-III in patients with terminal renal insufficiency treated with hemodialysis and following renal transplantation].
    Fassbinder W; Kühnl P; Neumayer HH; Offermann G; Seidl S; Schoeppe W
    Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1087-90. PubMed ID: 3015545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of Liaison XL automated immunoassay platform for blood-borne infection screening on hepatitis B, hepatitis C, HIV 1/2, HTLV 1/2 and Treponema pallidum serological markers.
    Malm K; Kragsbjerg E; Andersson S
    Transfus Med; 2015 Apr; 25(2):101-5. PubMed ID: 25779614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the indirect immunofluorescence assay as a confirmatory test for detecting antibodies to the human immunodeficiency virus.
    McHugh TM; Stites DP; Casavant CH; Carlson JR; Yee J; McVay PA; Busch MP; Levy JA
    Diagn Immunol; 1986; 4(5):233-40. PubMed ID: 3539456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-HTLV-III testing of blood donors: reproducibility and confirmability of commercial test kits.
    Holland PV; Richards CA; Teghtmeyer JR; Douville CM; Carlson JR; Hinrichs SH; Pedersen NC
    Transfusion; 1985; 25(4):395-7. PubMed ID: 2992129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of 3 immuno-enzyme kits for the detection of anti-LAV antibodies. Comparison with confirmation tests. Study Subgroup of the National Blood Transfusion Society].
    Rev Fr Transfus Immunohematol; 1985 Sep; 28(4):325-44. PubMed ID: 3001897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
    Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Licensed tests for antibody to human T-lymphotropic virus type III. Sensitivity and specificity.
    Petricciani JC
    Ann Intern Med; 1985 Nov; 103(5):726-9. PubMed ID: 2996408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of human T-lymphotropic virus type I screening using pooled sera.
    Chang CS; Wu YW; Pan YC; Chen ZY; Wang CS
    J Formos Med Assoc; 2002 Nov; 101(11):775-8. PubMed ID: 12517057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of using heat-inactivated serum with the Abbott human T-cell lymphotropic virus type III antibody test.
    Jungkind DL; DiRenzo SA; Young SJ
    J Clin Microbiol; 1986 Feb; 23(2):381-2. PubMed ID: 3009536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-HTLV-III screening of blood donors.
    Kühnl P; Seidl S; Holzberger G
    Vox Sang; 1986; 51 Suppl 1():15-20. PubMed ID: 3017001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.